Covid-19 Infection among Pregnant Women: An Overview of Diagnosis, Treatment and Clinical Management
Coronavirus affliction or more popularly called COVID-19 is popular to be led to by a novel coronavirus 2. COVID-19 has been identified expected originated in Wuhan, Hubei, China. This pandemic begun in December 2019, and since then it has spread across the realm within a short ending. In the current scenario, no specific antagonistic-viral drug is recommended for COVID-19 administration. Vulnerable populations, such as significant women polluted with COVID-19, must be identified and made inquiries on in order to effectively control morbidity and mortality. In India, very few case reports on COVID-19-polluted pregnant wives have been published, and no showed exclusive treatment code exists. This item summarizes a review of COVID-19 infection in meaningful women, including signs and manifestations, etiopathogenesis, risk factors, diagnosis, and attainable management. This survey may be helpful for healing professionals in terms of the efficient approach and limitations of the drugs used in the current administration, and it takes into account the election of drugs with special consideration paid to side belongings in order to improve motherly health, gestation, and birth outcomes.
Author(s) Details:
Laxmi Pattanashetti,
Department of Pharmacology, KLE College of Pharmacy, Hubli. (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka, India.
Santosh B. Patil,
Department of Pharmacology, KLE College of Pharmacy, Hubli. (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka, India.
Sanath Nyamgouda,
Department of Pharmacy Practice, KLE College of Pharmacy, Hubli. (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka, India.
Mahendrakumar R. Bhagiratha,
Department of Pharmacy Practice, KLE College of Pharmacy, Hubli. (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka, India.
Pramod C. Gadad,
Department of Pharmacology, KLE College of Pharmacy, Hubli. (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka, India.
Please see the link here: https://stm.bookpi.org/PRAMR-V6/article/view/9150
Keywords: Covid-19, pregnant women, pathogenesis, management